Viking Therapeutics at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Viking Therapeutics at ObesityWeek 2026 in National Harbor: Booth 632, Suite 16.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Viking Therapeutics San Diego, CA | |
Clinical-stage company developing VK2735, a dual GLP-1/GIP receptor agonist in Phase 3 for obesity, in injectable and oral forms. | Booth Exhibiting at Booth 632, Suite 16 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Find decision makers at Viking Therapeutics
Tell us what you sell and we’ll find the people at Viking Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction